| Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
|---|---|---|---|---|---|---|
|
Sup. Fig. 3 AB
Flach H et al. (2024) |
Xla wt + TMX (100mg/L)
NF32 (in situ hybridization) |
|
| Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
|---|---|---|---|---|---|---|
|
|
Sup. Fig. 3 AB
Flach H et al. (2024) |
Xla wt + TMX (100mg/L)
NF32 (in situ hybridization) |
|